John Farrell named as Chief Operating Officer of ProductLife

He brings a track record of working with R&D business functions in the pharma and medical devices industries

Life sciences outsourcing and consulting services specialist ProductLife Group (PLG) has named John Farrell as its Chief Operating Officer (COO) to strengthen its global footprint and integrate core capabilities.

Farrell has a 25-year track record working with R&D business functions in various parts of the pharmaceutical and medical devices industries. His experience covers regulatory affairs, regulatory operations, clinical development, medical affairs, manufacturing and quality. He joins PLG from CSC, where he was Head of Life Sciences, Regulatory Services, providing on-site and near shore services to US and EU clients as well as off-shore services based in China.

Farrell's appointment is in line with other leadership changes at PLG. Pierre Cuny recently announced his decision to split the functions of Chairman and CEO to reinforce the management structure. Cuny retains the role of Chairman while Adam Sherlock, formerly Group Chief of Sales, Marketing and Strategic Development, has been appointed CEO.

You may also like

Manufacturing

ProductLife Group expands life science services with milestone Pharma D&S acquisition

ProductLife Group has agreed the acquisition of the Italian company Pharma D&S Group which is a global provider of regulatory and compliance services for the life sciences industry
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Hybrid interferons: developing a novel drug class

With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with limited resources. These challenges can be further amplified if the candidate being developed is of an entirely novel drug class
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Manufacturing

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis
Manufacturing

Triple your efficiency with the new DrySyn Vortex

Boost productivity with temperature-controlled parallel reactions
Manufacturing

Five critical design elements for Pelton wheel turbine flowmeters

Titan Enterprises outlines the factors for cost-effective and reliable low-flow measurement
Subscribe now